Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antiangiogenesis drugs target specific cancers, mechanisms.

× No keyword cloud information.

5 in total

Review 1. Current status and perspective of angiogenesis and antivascular therapeutic strategy: non-small cell lung cancer.

Authors: Seiji Yano; Yuka Matsumori; Kenji Ikuta; Hirokazu Ogino; Tamir Doljinsuren; Saburo Sone
Journal: Int J Clin Oncol Date: 2006-04 Impact factor: 3.402

2. Platelet-derived growth factor receptor independent proliferation of human glioblastoma cells: selective tyrosine kinase inhibitors lack antiproliferative activity.

Authors: Dietmar Gross; Günther Bernhardt; Armin Buschauer
Journal: J Cancer Res Clin Oncol Date: 2006-05-31 Impact factor: 4.553

3. Differences of vascular endothelial growth factor (VEGF) expression between liver and abdominal metastases from colon cancer. Implications for the treatment with VEGF inhibitors.

Authors: S Cascinu; F Graziano; V Catalano; M P Staccioli; S Barni; P Giordani; M C Rossi; A M Baldelli; P Muretto; A Valenti; G Catalano
Journal: Clin Exp Metastasis Date: 2000 Impact factor: 5.150

Review 4. The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents.

Authors: Dietmar W Siemann
Journal: Cancer Treat Rev Date: 2010-06-08 Impact factor: 12.111

5. Vascular development in mouse lung metastases.

Authors: Howard W Salmon; Ananya Guha; Amyn M Rojiani; Dietmar W Siemann
Journal: Am J Cancer Res Date: 2012-08-20 Impact factor: 6.166

5 in total